Table 1.
Patient and treatment characteristics in study population
| All patients (n = 63) | Survivor (n = 38) | Non-survivor (n = 25) | P values | |
|---|---|---|---|---|
| Gender no (female) | 33 female | 21 female | 12 female | 0.57 |
| Age (years) (median (IQR)) | 6.47 (1–13) | 8.5 (1–13) | 2 (0.75–10) | 0.3 |
| Weight (kg) (median (IQR)) | 7.8 (10–54) | 11.2 (11.52–54) | 25 (7.5–50) | 0.12 |
| No of TPE sessions/patient (median (IQR)) | 5 (3–7) | 5 (5–7) | 4(2–6) | 0.06 |
| Mean plasma volume exchanged | 1.34 ± 0.21 | 1.35 ± 0.18 | 1.32 ± 0.25 | 0.6 |
| CKRT days (median (IQR)) | 12 (6–37) | 13 (6–39) | 12 (7–24) | 0.7 |
| PRISM score on admission (mean ± SD) | 14.09 ± 6.33 | 12.6 ± 5.8 | 16.16 ± 6.54 | 0.031 |
| PELOD score at start of CKRT (median (IQR)) | 20 (11–22) | 12 (10.5–22) | 22 (12–22) | 0.16 |
| Time to initiation of TPE from PICU admission (days) (median (IQR)) | 2 (1–6) | 2 (1–3) | 4 (2–13) | 0.029 |
| Time to initiation of CKRT from PICU admission (days) (median (IQR)) | 1 (1–4) | 1 (1–2) | 3 (1.9) | 0.02 |
| ECMO (n:15) days on ECMO (median, IQR) | 13 (6–27) | 11 (6–17) | 17 (3–40) |